Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Calculate exactly how many units of IGF-1 LR3 to draw on your syringe. Pre-filled with standard defaults.
Draw on your syringe
0.80
units
(0.008 mL)
0.8% of syringe capacity
Concentration
2,500
mcg/mL
Dose volume
0.008
mL
Doses per vial
250
doses
Cost per dose
---
enter price
Total mcg in vial = 5 mg x 1000 = 5,000 mcg
Concentration = 5,000 mcg / 2 mL = 2,500 mcg/mL
Dose volume = 20 mcg / 2,500 mcg/mL = 0.0080 mL
Units to draw = 0.0080 mL x 100 units/mL = 0.80 units
Doses per vial = 5,000 mcg / 20 mcg = 250 doses
Want the full Disclosed Trust Index?
Create a free account to unlock vendor trust scores, the COA scanner, the Forgery Map, and lot lookup across the corpus.
Create a free accountIGF-1 LR3 is an 83-amino-acid modified IGF-1 analog with a 13-residue N-terminal extension (MFPAMPLSSLFVN) and an Arg-3 substitution. These modifications reduce binding to IGF binding proteins (IGFBPs), extending effective half-life and increasing tissue bioavailability relative to native IGF-1. It is a research/cell-culture reagent and is NOT FDA-approved for any human use. Do not confuse with mecasermin (Increlex), which is recombinant human IGF-1 and IS FDA-approved for severe primary IGF-1 deficiency.
Common vial size
5
mg
Typical BAC water
2
mL
Dose range
20–50
mcg
Default dose
20
mcg
Store refrigerated (2-8°C). Once reconstituted, use within 28 days.
Disclosed Labs